
Octreotide Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL
Reference Brands: Sandostatin.(EU & US)
Category: Oncology Cancer Care
Octreotide Injection is available in Injection and strengths such as 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Octreotide Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Octreotide Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Octreotide Injection 50 mcg/mL, 100 mcg/mL, 200 mcg/mL, and 500 mcg/mL is used to manage symptoms and control the growth of neuroendocrine tumors in oncology. Primarily indicated for carcinoid tumors, GEP-NETs, and acromegaly, Octreotide works by mimicking the effects of somatostatin, regulating hormone production. It is available in subcutaneous or IV formulations and is a vital part of oncology B2B distribution in both the U.S. and EU, ensuring better symptom management and tumor control for patients suffering from neuroendocrine malignancies and related conditions.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers